| Literature DB >> 31517785 |
Nikhilesh R Mazumder1, Kofi Atiemo1, Matthew Kappus2, Giuseppe Cullaro3, Matthew E Harinstein4, Daniela Ladner1, Elizabeth Verna5, Jennifer Lai3, Josh Levitsky1.
Abstract
Risk scoring for patients with cirrhosis has evolved greatly over the past several decades. However, patients with low Model for End-Stage Liver Disease-Sodium scores still suffer from liver-related morbidity and mortality. Unfortunately, it is not clear which of these low Model for End-Stage Liver Disease-Sodium score patients would benefit from earlier consideration of liver transplantation. This article reviews the literature of risk prediction in patients with cirrhosis, identifies which patients may benefit from earlier interventions, such as transplantation, and proposes directions for future research.Entities:
Mesh:
Year: 2020 PMID: 31517785 PMCID: PMC6994330 DOI: 10.1097/TP.0000000000002956
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 5.385